{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T03:31:07Z","timestamp":1782012667839,"version":"3.54.5"},"reference-count":29,"publisher":"BMJ","issue":"12","funder":[{"name":"Hull and East Riding Cardiac Trust","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2024,3,15]]},"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Loop diuretics are commonly prescribed in the community, not always to patients with a recorded diagnosis of heart failure (HF). The rate of HF events in patients prescribed loop diuretics without a diagnosis of HF is unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a propensity-matched cohort study using data from the Clinical Practice Research Datalink, Hospital Episode Statistics and Office of National Statistics in the UK. Patients prescribed a loop diuretic without a diagnosis of HF (loop diuretic group) between 1 January 2010 and 31 December 2015 were compared with patients with HF (HF group)\u2014analysis A, and patients with risk factors for HF (either ischaemic heart disease, or diabetes <jats:italic>and<\/jats:italic> hypertension\u2014at-risk group)\u2014analysis B. The primary endpoint was an HF event (a composite of presentation with HF symptoms, HF hospitalisation, HF diagnosis (analysis B only) and all-cause mortality).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>From a total population of 180\u2009384 patients (78\u2009968 in the loop diuretic group, 28\u2009177 in the HF group and 73\u2009239 in the at-risk group), there were 59\u2009694 patients, 22\u2009352 patients and 57\u2009219 patients in the loop diuretic, HF and at-risk groups, respectively, after exclusion criteria were applied. After propensity matching for age, sex and comorbidities, patients in the loop diuretic group had a similar rate of HF events as those in the HF group (71.9% vs 72.1%; HR=0.92 (95% CI 0.90 to 0.94); p&lt;0.001), and twice as those in the at-risk group (59.2% vs 35.7%; HR=2.04 (95% CI 2.00 to 2.08); p&lt;0.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients prescribed a loop diuretic without a recorded diagnosis of HF experience HF events at a rate comparable with that of patients <jats:italic>with<\/jats:italic> a recorded diagnosis of HF; many of these patients may have undiagnosed HF.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2023-323577","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T13:20:33Z","timestamp":1713360033000},"page":"854-862","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study"],"prefix":"10.1136","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-3062","authenticated-orcid":false,"given":"Joseph James","family":"Cuthbert","sequence":"first","affiliation":[{"name":"Clinical Sciences Centre, Hull York Medical School, University of Hull, Hull, UK"},{"name":"Department of Cardiology, Castle Hill Hospital, Cottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ireneous","family":"Soyiri","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Applied Health Research, Hull York Medical School, University of Hull, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Jayne","family":"Lomax","sequence":"additional","affiliation":[{"name":"Cottingham Medical Centre, Cottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Turgoose","sequence":"additional","affiliation":[{"name":"Hull Health Trials Unit, Hull York Medical School, University of Hull, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Fuat","sequence":"additional","affiliation":[{"name":"GP, County Durham and Darlington NHS Foundation Trust, Darlington Memorial Hospital, Darlington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Cohen","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Applied Health Research, Hull York Medical School, University of Hull, Hull, UK"},{"name":"Hull Health Trials Unit, Hull York Medical School, University of Hull, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8362-668X","authenticated-orcid":false,"given":"Andrew L","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Castle Hill Hospital, Cottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"2025092013480241000_110.12.854.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2025092013480241000_110.12.854.2","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/ejhf.1111","article-title":"How accurate is clinical assessment of neck veins in the estimation of central venous pressure in acute heart failure? Insights from a prospective study","volume":"20","author":"Breidthardt","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2025092013480241000_110.12.854.3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl233"},{"key":"2025092013480241000_110.12.854.4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/echo.15073","article-title":"Variability of echocardiographic measures of left ventricular diastolic function. The HUNT study","volume":"38","author":"Letnes","year":"2021","journal-title":"Echocardiography"},{"key":"2025092013480241000_110.12.854.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.01.037"},{"key":"2025092013480241000_110.12.854.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32520-5"},{"key":"2025092013480241000_110.12.854.7","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-321702"},{"key":"2025092013480241000_110.12.854.8","doi-asserted-by":"publisher","DOI":"10.1157\/13126044"},{"key":"2025092013480241000_110.12.854.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(02)00034-X"},{"key":"2025092013480241000_110.12.854.10","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/ejhf.2143","article-title":"The heart failure association Atlas: heart failure epidemiology and management statistics","volume":"23","author":"Seferovi\u0107","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2025092013480241000_110.12.854.11","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"2025092013480241000_110.12.854.12","unstructured":"National Health Service Digital . Quality and outcomes framework (QOF), 2019-20. Available: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/quality-and-outcomes-framework-achievement-prevalence-and-exceptions-data\/2019-20 [Accessed 13 Feb 2023]."},{"key":"2025092013480241000_110.12.854.13","unstructured":"National Institute for Health and Care Excellence . British national Formulary [Diuretics]. Treatment summaries. Available: https:\/\/bnf.nice.org.uk\/treatment-summaries\/diuretics [Accessed 28 Feb 2023]."},{"key":"2025092013480241000_110.12.854.14","doi-asserted-by":"publisher","DOI":"10.1177\/2047487318810839"},{"key":"2025092013480241000_110.12.854.15","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv098"},{"key":"2025092013480241000_110.12.854.16","unstructured":"National Institute for Health and Care Excellence (NICE) . Chronic heart failure in adults: diagnosis and management [NICE guideline NG106]. Overview | Chronic heart failure in adults: diagnosis and management | Guidance | NICE; 2018."},{"key":"2025092013480241000_110.12.854.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099825","article-title":"Clinicalcodes: an online clinical codes repository to improve the validity and reproducibility of research using electronic medical records","volume":"9","author":"Springate","year":"2014","journal-title":"PLoS One"},{"key":"2025092013480241000_110.12.854.18","unstructured":"National Health Service Digital . Read codes, 2022. Available: https:\/\/digital.nhs.uk\/services\/terminology-and-classifications\/read-codes [Accessed 3 Mar 2023]."},{"key":"2025092013480241000_110.12.854.19","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2022.06","article-title":"Epidemiology and clinical features of heart failure with preserved ejection fraction","volume":"8","author":"Teramoto","year":"2022","journal-title":"Card Fail Rev"},{"key":"2025092013480241000_110.12.854.20","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.813"},{"key":"2025092013480241000_110.12.854.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30748-0"},{"key":"2025092013480241000_110.12.854.22","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.65"},{"key":"2025092013480241000_110.12.854.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107038"},{"key":"2025092013480241000_110.12.854.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206286"},{"key":"2025092013480241000_110.12.854.25","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-022-00551-4"},{"key":"2025092013480241000_110.12.854.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjhci-2022-100718","article-title":"Survival and health economic outcomes in heart failure diagnosed at hospital admission versus community settings: a propensity-matched analysis","volume":"30","author":"Bachtiger","year":"2023","journal-title":"BMJ Health Care Inform"},{"key":"2025092013480241000_110.12.854.27","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.709"},{"key":"2025092013480241000_110.12.854.28","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2017-312183"},{"key":"2025092013480241000_110.12.854.29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005540","article-title":"Validation of chronic obstructive pulmonary disease recording in the clinical practice research datalink (CPRD-GOLD)","volume":"4","author":"Quint","year":"2014","journal-title":"BMJ Open"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2023-323577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:48:11Z","timestamp":1758401291000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2023-323577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,5,23]]},"published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1136\/heartjnl-2023-323577"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2023-323577","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]}}}